NCT Number: NCT00641875
The Effect of Nocturnal Haemodialysis on Arterial Stiffness
Arterial stiffness refers to the accumulation of extracellular deposits of matrix and calcium which reduce blood vessel compliance. Although there is growing evidence that increased arterial stiffness is associated with chronic kidney disease (CKD), its pathogenesis is unclear. Pulse wave velocity (PWV) and augmentation index (AIx) provide tools for estimating arterial stiffness, and therefore predicting cardiovascular morbidity and mortality. The aims of the study are: (1) compare the effects of nocturnal and conventional haemodialysis on arterial stiffness, and (2) examine the relationship between arterial stiffness and clinical and biochemical parameters.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–80 year
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- adult dialysis patients
- able to perform home nocturnal haemodialysis
Exclusion criteria
- age < 18 and > 80 years
- any patient who is anticipating a live renal transplantation in forthcoming 12 months
Treatment and study plan
Primary outcomes
-
To purpose of this study is to evaluate the arterial stiffness in subjects who have undergone 12 months nocturnal haemodialysis.
Time frame: 12 months
Secondary outcomes
-
To examine the relationship between arterial stiffness and clinical and biochemical parameters
Time frame: 12 months
Sponsors and collaborators
Lead sponsor
Melbourne Health
Other
Registry information
Important dates
- Study start
- 2005
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Mar 24, 2008
- Registry last updated
- Apr 27, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Association of Middle Molecules Clearance With HDF Volume
NCT06515899
Chronic Disease, Disease Attributes
Stevenage, Hertfordshire, United Kingdom
View Trial DetailsVIRTUUS Children's Study
NCT03719339
Acute Cellular Graft Rejection, Antibody-mediated Rejection
La Jolla, California, United States
View Trial DetailsSafety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients
NCT04817774
Chronic Disease, Disease Attributes
Leuven, Belgium
View Trial DetailsCommunication During Hospitalization About Resuscitation Trial
NCT02984124
Chronic Disease, Disease Attributes
Chapel Hill, North Carolina, United States
View Trial Details